{
 "as_of": "2026-11-06",
 "cmr": "fi-cm-kg/FSME/FI4000153309",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Faron Pharmaceuticals Oy (First North Finland: FI4000153309) — research page\n\nAs of 2026-11-06 · fi-cm-kg · record version 1\n\n## Identity and listing\n\nFaron Pharmaceuticals Oy is listed on First North Finland under ticker FI4000153309, ISIN FI4000153309 and LEI 7437009H31TO1DC0EB42. Security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 95 filings in the twelve months to 2026-11-06, across 74 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-11-04 and is of type Investor News, 2 days before the record date. The exchange median cadence gap is 7.0 days, the exchange median filings count is 39.5 and the exchange median latency is 9.0 days, across 48 issuers on First North Finland. The sector median is not on the record.\n\n## Auditor\n\nThe auditor of record is not on the record, and neither its location nor any auditor change is on the record, because the record does not carry lifecycle types for this register.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move lines for this register, as no lifecycle type map is yet in place. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under acm-68000/fi/mifid-ii-product-governance/r1, because the chapter as of 2026-11-04 carries no client categories. The outcome therefore cannot name its client category.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page in the pages read.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date of the market and the start of the live record are not on the record.\n\n## Sources\n\n5 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mcp.fi-cm-kg.ai/events/FSME/FI4000153309 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterHEX|FirstNorthInformationHEX (the halt flag)\n- https://fi.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.fi-cm-kg.ai/record/FSME/FI4000153309 (the record)\n",
 "market": "FI",
 "node": "fi-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the FI vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "FI",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "FI",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "FI",
    "state": "not_on_record"
   },
   "changes": {
    "market": "FI",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "fi-cm-kg/FSME/FI4000153309",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 48,
     "median_cadence_gap_days": 7,
     "median_filings": 39.5,
     "median_latency_days": 9,
     "name": "First North Finland"
    },
    "sector": {
     "market": "FI",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 2,
    "Changes in board/management/certified adviser/auditor/liquidity provider": 3,
    "Company Announcement": 24,
    "Company description / prospectus": 1,
    "Decisions of general meeting": 2,
    "Financial calendar": 2,
    "Financial statement release": 1,
    "Half year financial report": 1,
    "Investor News": 16,
    "Major shareholder announcements": 26,
    "Managers' Transactions": 8,
    "Notice to general meeting": 2,
    "Other information disclosed according to the rules of the Exchange": 7
   },
   "cadence_median_gap_days": 4,
   "filing_days": 74,
   "filings": 95,
   "latency_days": 2,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-11-04",
     "source": "https://view.news.eu.nasdaq.com/view?id=bc24ee49bf6c293f38b2c124b2b10ece0&lang=en&src=listed",
     "title": "Faron Announces Five ASH 2026 Abstracts Spanning Bexmarilimab, Clever-1 and Higher-Risk MDS Outcomes",
     "type": "Investor News"
    },
    {
     "category": "Company Announcement",
     "date": "2026-10-19",
     "source": "https://view.news.eu.nasdaq.com/view?id=b0f5040594966aa400e80fffec9c956f7&lang=en&src=listed",
     "title": "Faron to Report Final Melanoma Survival Data from the MATINS Study at ESMO 2026",
     "type": "Company Announcement"
    },
    {
     "category": "Investor News",
     "date": "2026-10-08",
     "source": "https://view.news.eu.nasdaq.com/view?id=b183420203e10e7c2d14eeb0ef27b3574&lang=en&src=listed",
     "title": "Faron Pharmaceuticals Ltd: Reminder for investors, analysts and media to register for upcoming R&D Day",
     "type": "Investor News"
    },
    {
     "category": "Company Announcement",
     "date": "2026-10-06",
     "source": "https://view.news.eu.nasdaq.com/view?id=be0d9370b4f6092db168ae4381077bece&lang=en&src=listed",
     "title": "Composition of Faron Pharmaceutical's Shareholders' Nomination Board",
     "type": "Company Announcement"
    },
    {
     "category": "Investor News",
     "date": "2026-10-01",
     "source": "https://view.news.eu.nasdaq.com/view?id=b71f3bd87028e558de1f1b2de2dc7fb94&lang=en&src=listed",
     "title": "Faron Announces First Patient Dosed in BLAZE Investigator-Initiated Trial",
     "type": "Investor News"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.fi-cm-kg.ai/events/FSME/FI4000153309",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "eu-sources/fi/roster.py (FIRDS https://registers.esma.europa.eu/solr/esma_registers_firds_files/select)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Finland"
   },
   "isin": {
    "read_by": "eu-sources/fi/roster.py (FIRDS https://registers.esma.europa.eu/solr/esma_registers_firds_files/select)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "FI4000153309"
   },
   "jurisdiction": {
    "market": "FI",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "eu-sources/fi/roster.py (FIRDS https://registers.esma.europa.eu/solr/esma_registers_firds_files/select)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "filled",
    "value": "7437009H31TO1DC0EB42"
   },
   "name": {
    "read_by": "eu-sources/fi/roster.py (FIRDS https://registers.esma.europa.eu/solr/esma_registers_firds_files/select)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Faron Pharmaceuticals Oy"
   },
   "sector": {
    "market": "FI",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "FI",
    "state": "not_on_record"
   },
   "segment": {
    "market": "FI",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "eu-sources/fi/roster.py (FIRDS https://registers.esma.europa.eu/solr/esma_registers_firds_files/select)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "FI4000153309"
   },
   "website": {
    "market": "FI",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "FI",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "FI",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "FI",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "FI",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "FI",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "FI",
  "node": "fi-cm-kg",
  "numbers_hash": "sha256:581f34f17ad8164f6a641fa8ee501c03aac0164c10b8284bd5907a3e624e89ab",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://fi.eu-cm-kg.ai/book/aio.json",
    "door": "https://fi.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/fi/mifid-ii-product-governance/r1",
   "section": "fi.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.fi-cm-kg.ai/record/FSME/FI4000153309",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterHEX|FirstNorthInformationHEX",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:581f34f17ad8164f6a641fa8ee501c03aac0164c10b8284bd5907a3e624e89ab",
 "path": "/fi/FSME/FI4000153309",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Faron Pharmaceuticals Oy is listed on First North Finland under ticker FI4000153309, ISIN FI4000153309 and LEI 7437009H31TO1DC0EB42. Security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 95 filings in the twelve months to 2026-11-06, across 74 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-11-04 and is of type Investor News, 2 days before the record date. The exchange median cadence gap is 7.0 days, the exchange median filings count is 39.5 and the exchange median latency is 9.0 days, across 48 issuers on First North Finland. The sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and neither its location nor any auditor change is on the record, because the record does not carry lifecycle types for this register.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move lines for this register, as no lifecycle type map is yet in place. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under acm-68000/fi/mifid-ii-product-governance/r1, because the chapter as of 2026-11-04 carries no client categories. The outcome therefore cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page in the pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date of the market and the start of the live record are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "5 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.fi-cm-kg.ai/events/FSME/FI4000153309"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterHEX|FirstNorthInformationHEX"
  },
  {
   "for": "the orderability chapter",
   "source": "https://fi.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.fi-cm-kg.ai/record/FSME/FI4000153309"
  }
 ],
 "title": "Faron Pharmaceuticals Oy (FI4000153309) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}